Zhouliang Wu

Department of Urology, The Second Hospital of Tianjin Medical University

Affiliated withThe Second Hospital of Tianjin Medical University Tianjin Institute of Urology

Research Area

Biography

Zhouliang Wu has not added Biography.
If you are Zhouliang Wu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Biochemical and biophysical research communications\| PubMed ID: 26551459	2015
Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospec... Medicine\| PubMed ID: 26844474	2016
Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study. OncoTargets and therapy\| PubMed ID: 26869805	2016
The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population. OncoTargets and therapy\| PubMed ID: 27022277	2016
The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis. World journal of surgical oncology\| PubMed ID: 27549155	2016
Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor. Oncotarget\| PubMed ID: 29719631	2018
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer. Cancer science\| PubMed ID: 30407690	2019
RAB38 promotes bladder cancer growth by promoting cell proliferation and motility. World journal of urology\| PubMed ID: 30535713	2019
KIF5A Promotes Bladder Cancer Proliferation and . Disease markers\| PubMed ID: 31354888	2019
Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer. International journal of clinical and experimental pathology\| PubMed ID: 31966702	2017
Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer medicine\| PubMed ID: 32250047	2020
Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer. Combinatorial chemistry & high throughput screening\| PubMed ID: 32940175	2021
Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer. Oncology reports\| PubMed ID: 33000254	2020
Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Acta histochemica\| PubMed ID: 34175686	2021
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway. Ecotoxicology and environmental safety\| PubMed ID: 35660381	2022
Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction. Disease markers\| PubMed ID: 35983409	2022
Corrigendum to "Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis" [Acta Histochem. 123(5) (2021) 151745]. Acta histochemica\| PubMed ID: 36180249	2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. Frontiers in oncology\| PubMed ID: 36300085	2022
Construction and validation of a bladder cancer risk model based on autophagy-related genes. Functional & integrative genomics\| PubMed ID: 36689018	2023
Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS). Frontiers in cellular and infection microbiology\| PubMed ID: 36936777	2023
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis. Frontiers in genetics\| PubMed ID: 37091788	2023
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data. Heliyon\| PubMed ID: 37346342	2023
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data. Functional & integrative genomics\| PubMed ID: 37358720	2023
Withdrawal notice to: "Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data" [Heliyon 9, (2023) 16897]. Heliyon\| PubMed ID: 37484247	2023
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. BMC medical genomics\| PubMed ID: 37880682	2023
SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer. Translational andrology and urology\| PubMed ID: 38196702	2023
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis. Heliyon\| PubMed ID: 38560150	2024
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis. Technology and health care : official journal of the European Society for Engineering and Medicine\| PubMed ID: 39031404	2024
An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data. Life sciences\| PubMed ID: 39034028	2024
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer. Nano letters\| PubMed ID: 39136297	2024